CN107164553A - Reps1在制备儿童i型糖尿病诊断产品中的用途 - Google Patents
Reps1在制备儿童i型糖尿病诊断产品中的用途 Download PDFInfo
- Publication number
- CN107164553A CN107164553A CN201710592874.4A CN201710592874A CN107164553A CN 107164553 A CN107164553 A CN 107164553A CN 201710592874 A CN201710592874 A CN 201710592874A CN 107164553 A CN107164553 A CN 107164553A
- Authority
- CN
- China
- Prior art keywords
- reps1
- children
- diabetes
- genes
- albumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710592874.4A CN107164553A (zh) | 2017-07-19 | 2017-07-19 | Reps1在制备儿童i型糖尿病诊断产品中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710592874.4A CN107164553A (zh) | 2017-07-19 | 2017-07-19 | Reps1在制备儿童i型糖尿病诊断产品中的用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107164553A true CN107164553A (zh) | 2017-09-15 |
Family
ID=59817149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710592874.4A Pending CN107164553A (zh) | 2017-07-19 | 2017-07-19 | Reps1在制备儿童i型糖尿病诊断产品中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107164553A (zh) |
-
2017
- 2017-07-19 CN CN201710592874.4A patent/CN107164553A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105907870A (zh) | Dhx36作为冠心病诊断标志物的用途 | |
CN107022637A (zh) | 一种与重度抑郁症相关的基因标志物 | |
CN107227358A (zh) | Numb在绝经后妇女原发性骨质疏松症诊断或预后中的用途 | |
CN110656169B (zh) | 心房颤动的诊断标志物 | |
CN115948544B (zh) | Cited4和/或metrn在椎间盘退变程度的鉴别诊断中的应用 | |
CN105821152B (zh) | 冠心病生物标志物 | |
CN105543400B (zh) | I型糖尿病的分子标志物 | |
KR101745297B1 (ko) | 비만 진단용 조성물 및 이의 용도 | |
CN106048005B (zh) | 一种诊断冠心病的分子标志物 | |
CN107164551A (zh) | Ubap2l在儿童i型糖尿病诊断或预后中的用途 | |
CN107164553A (zh) | Reps1在制备儿童i型糖尿病诊断产品中的用途 | |
CN107022633A (zh) | 用于诊断强直性脊柱炎的基因标志物 | |
CN105907871B (zh) | 用于诊断冠心病的生物标志物 | |
CN106048006B (zh) | Smchd1在制备诊断冠心病产品中的应用 | |
CN106520970B (zh) | 用于诊断脑卒中的标志物 | |
CN108559775A (zh) | 登革热和登革出血热诊断区分标志物 | |
CN106755426A (zh) | Ifi27在制备诊断布加综合征产品中的用途 | |
CN107164552A (zh) | Mon1b在诊断儿童i型糖尿病中的新用途 | |
CN107012236A (zh) | Skil作为诊断冠心病的分子标志物 | |
CN107058566A (zh) | Lsmem1基因作为强直性脊柱炎的诊断工具 | |
CN107012254A (zh) | Klhl22基因及其表达产物在制备诊断产品中的应用 | |
KR102622108B1 (ko) | 장내 미생물을 이용한 신질환 위험도 예측 또는 진단용 조성물, 그를 이용한 진단키트, 정보제공방법 및 신질환 예방 또는 치료제 스크리닝 방법 | |
CN106435009B (zh) | Tubb2a作为血液诊断标志物的用途 | |
CN105648074B (zh) | Fan1基因在ii型糖尿病诊断中的应用 | |
CN106435011B (zh) | Myom2的诊断用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Room 1210, Building 3, Ronghua Xintai Building, 10 Ronghua South Road, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing Applicant after: BEIJING MEDINTELL BIOMED Co.,Ltd. Address before: 100080 Beijing city Haidian District Shanyuan Street No. 1 cubic court building room 3103 Applicant before: BEIJING MEDINTELL BIOMED Co.,Ltd. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200302 Address after: Room 2503, Qianshan building, building D2, Qingdao International Innovation Park Phase II, No. 1, Keyuan Weiyi Road, Laoshan District, Qingdao, Shandong Province Applicant after: Qingdao Yangshen biomedical Co.,Ltd. Address before: Room 1210, Building 3, Ronghua Xintai Building, 10 Ronghua South Road, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing Applicant before: BEIJING MEDINTELL BIOMED Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170915 |
|
RJ01 | Rejection of invention patent application after publication |